Skip to content

Potentially inappropriate medication according to the PRISCUS2.0 list: Inpatient sample regarding alternative drugs and the reasons for prescription

Potentially inappropriate medication according to the PRISCUS2.0 list: Inpatient sample regarding alternative drugs and the reasons for prescription

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033602
Enrollment
300
Registered
2024-02-09
Start date
2024-02-10
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medication in older patients

Interventions

Group 1: 300 male and female patients between 65 and 100 years of age with prescription of at least 1 drug at discharge 1) Analysis of the medication at discharge for the prescription of PIMs accordin

Sponsors

Malteser Waldkrankenhaus St. Marien Erlangen, Geriatrie-Zentrum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: - Prescription of at least one drug in the medication at discharge - Written informed consent

Exclusion criteria

Exclusion criteria: - younger than 65 years of age - no drug use at discharge - patients under legal supervision - no written informed consent

Design outcomes

Primary

MeasureTime frame
Percentage of avoidable prescriptions of potentially inappropriate medication regarding all prescriptions of potentially inappropriate medication in the inpatient sample

Secondary

MeasureTime frame
- Ranking of most affected groups of drugs - Percentage of the reasons for prescribing potentially inappropriate medication despite suggestion of alternative drugs in the PRISCUS 2.0 list which are more harmless

Countries

Germany

Contacts

Public ContactBirgit Deutsch

Malteser Waldkrankenhaus St. Marien Erlangen, Geriatrie-Zentrum

birgit.deutsch@waldkrankenhaus.de+4991318220

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026